Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Cardiol Young. 2016 Nov 10;27(6):1090–1097. doi: 10.1017/S1047951116002092

Table 3.

Case descriptions for previously under-recognized Melody® valve post-procedural adverse events

Time after implant (mos) Event description and circumstances Outcome Source
Type III stent fracture (complete fracture with stent fragment embolization) 7 Location of fragment not noted Surgical valve removal MAUDE
35 Fragment embolized to right ventricle apex Details not provided MAUDE
12 Fragment embolized to right ventricle apex Fragment left in place, 2nd trans-catheter valve implanted MAUDE
24 Fragment embolized to branch pulmonary artery Fragment retrieved, 2nd trans-catheter valve implanted MAUDE
98 Fragment embolized to left lung No intervention required MAUDE
Device erosion / aortopulmonary fistula 0.75 Valve erosion into ascending aorta in patient with history of Ross procedure, presented with heart failure Surgical valve removal Taggart (2013) Congenital Heart Disease
0.75 Fistula between aortic root and conduit in patient with history of interrupted aortic arch repair Surgical valve removal Peer (2014) Journal of Thoracic and Cardiovascular Surgery
16 Valve erosion into ascending aorta with shunt causing “severe” heart failure Surgical valve removal MAUDE
36 Valve erosion into ascending aorta in a patient with history of Ross-Konno operation, presented with heart failure Surgical valve removal MAUDE
Late coronary obstruction 0.2 LAD obstruction presenting 5 days after implant; intra-procedural coronary compression resolved with nitroglycerin administration and was attributed to vasospasm Surgical valve removal Biermann (2012) Thoracic and Cardiovascular Surgeon
3 Late right coronary artery dissection and obstruction after exercise, felt to be related to increased cardiac output Surgical valve removal and right coronary artery re-implantation Deghani (2015) Catheterization and Cardiovascular Interventions